Fluconazole susceptibilities of Candida species and distribution of species recovered from blood cultures over a 5-year period
Open Access
- 1 June 1994
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 38 (6) , 1422-1424
- https://doi.org/10.1128/aac.38.6.1422
Abstract
The distribution and fluconazole susceptibilities of Candida species isolated over a 5-year period were investigated. Susceptibilities were determined by using a new microtiter procedure and the National Committee for Clinical Laboratory Standards (NCCLS) proposed standard. The new method correlated well with the NCCLS proposed standard and gave very clear end points. Results indicate that there are species-related differences in MICs as reflected in the MICs for 90% of species tested. Candida albicans is most susceptible to fluconazole, while Candida glabrata is among the least susceptible. These findings coincided with the observation of a shift in distribution of yeast species recovered from blood cultures from 1987 to 1992. C. albicans was the predominant species (87%) in the pre- or early fluconazole years but decreased to only 31% of the isolates in 1992. Thus, Candida species for which MICs of fluconazole were higher have become more prominent in recent years. Significantly, throughout this period, MICs for each species did not change appreciably.Keywords
This publication has 4 references indexed in Scilit:
- Standardized susceptibility testing of fluconazole: an international collaborative studyAntimicrobial Agents and Chemotherapy, 1992
- Fluconazole susceptibility testing of Candida albicans: microtiter method that is independent of inoculum size, temperature, and time of readingAntimicrobial Agents and Chemotherapy, 1991
- Progress in Standardizing Antifungal Susceptibility TestsClinics In Laboratory Medicine, 1989
- Growth phase in relation to ketoconazole and miconazole susceptibilities of Candida albicansAntimicrobial Agents and Chemotherapy, 1984